Improved contamination control for a rapid phage-based rifampicin resistance test for Mycobacterium tuberculosis
Authors:
Open Access
- 1 October 2007
- journal article
- research article
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 56 (10) , 1334-1339
Abstract
A prospective study was conducted of the rapid FASTPlaque-Response test for determination of rifampicin resistance in Mycobacterium tuberculosis with and without the addition of an antimicrobial supplement containing nystatin, oxacillin and aztreonam (NOA) to control specimen-related contamination. A total of 631 smear-positive sputum specimens was tested. The age of specimens ranged from 0 to 21 days. The NOA antimicrobial was effective at controlling contamination, with 4.1 % of specimens contaminated when the NOA antimicrobial supplement was used compared with 13.9 % contamination without NOA. Overall levels of interpretability of the test with NOA were 87.8 % with specimens of ≤3 days and 79.0 % for all specimens. This compared with 70.1 and 73.8 % readable results, respectively, from conventional culture-based drug susceptibility testing (DST). Sensitivity, specificity and overall accuracy of the FASTPlaque-Response test for rifampicin resistance were 98.1, 96.3 and 96.6 %, respectively, for all specimens with NOA, and 93.2, 96.3 and 95.9 % without NOA, when compared with resolved conventional DST results. Inclusion of the NOA supplement reduced contamination, increased the number of interpretable results and did not adversely affect the performance of the FASTPlaque-Response test. Thus, the use of NOA improves the robustness of the test, facilitating its wider implementation.Keywords
This publication has 11 references indexed in Scilit:
- New tools and emerging technologies for the diagnosis of tuberculosis: Part II. Active tuberculosis and drug resistanceExpert Review of Molecular Diagnostics, 2006
- A commercial line probe assay for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysisBMC Infectious Diseases, 2005
- Meta-Analysis of BACTEC MGIT 960 and BACTEC 460 TB, with or without Solid Media, for Detection of MycobacteriaJournal of Clinical Microbiology, 2004
- The use of a novel phage-based technology as a practical tool for the diagnosis of tuberculosis in AfricaAFRICAN JOURNAL OF BIOTECHNOLOGY, 2003
- Feasibility and cost-effectiveness of standardised second-line drug treatment for chronic tuberculosis patients: a national cohort study in PeruThe Lancet, 2002
- Performance of a rapid phage-based test, FASTPlaqueTB™, to diagnose pulmonary tuberculosis from sputum specimens in South AfricaThe International Journal of Tuberculosis and Lung Disease, 2002
- Detection of mutations in drug resistance genes of Mycobacterium tuberculosis by a dot-blot hybridization strategyTubercle and Lung Disease, 1999
- Evaluation of a new rapid bacteriophage-based method for the drug susceptibility testing of Mycobacterium tuberculosisNature Medicine, 1997
- Rapid Assessment of Drug Susceptibilities of Mycobacterium tuberculosis by Means of Luciferase Reporter PhagesScience, 1993
- Clinical Presentation and Outcome of Patients with HIV Infection and Tuberculosis Caused by Multiple-Drug-resistant BacilliAnnals of Internal Medicine, 1992